The Mississippi House of Representatives unanimously passed legislation Wednesday that would require state-regulated health insurance plans to cover biomarker testing, a technology that helps ensure cancer patients get the correct treatment for the type of cancer they are faced with. Biomarker testing analyzes biological indicators, often through blood or tissue samples, to help doctors identity which treatments are most likely to be effective for a specific cancer. The bill is being referred to as “Jill’s Law” in honor of the late wife of Rep. Casey Eure, R-Saucier, who used biomarker testing following her cancer diagnosis. “In the case of a cancer diagnosis, biomarker testing helps doctors develop a personalized treatment plan so some patients can avoid treatments that won’t work for their individual disease. Everyone who can benefit from biomarker testing deserves access.”The bill now heads to the Senate, where if it passes without amendments, it will go to Gov.